The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of multiple myeloma.
The following sections include:
- Associated ICD-9-CM codes used for the classification of multiple myeloma
- Drugs that have been FDA approved in the treatment of multiple myeloma
- Drugs that are Compendia-listed for off-label use for multiple myeloma based on clinical studies that suggest beneficial use in some cases. Please note: If a check mark appears in the FDA column, it will NOT appear in the Compendia off-label use column
- Corresponding HCPCS/CPT® codes and code descriptions
